Independent Director · IRONWOOD PHARMACEUTICALS INC (IRWD)

Chair, Audit Committee

Catherine Moukheibir — IRONWOOD PHARMACEUTICALS Director Compensation (2025)

Fiscal year 2025 director compensation for Catherine Moukheibir at IRONWOOD PHARMACEUTICALS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

IRONWOOD PHARMACEUTICALS Director Compensation Table · the one fiscal year held
In US dollars, as IRONWOOD PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$75,000$35,960—$0$110,960

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IRONWOOD PHARMACEUTICALS INC DEF 14A filed April 28, 2026, accession 0001104659-26-050325, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

IRONWOOD PHARMACEUTICALS pays directors a $50,000 cash retainer and $250,000 in Restricted Stock.

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the IRONWOOD PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alexander DennerIndependent Director$95,944
Jay ShepardIndependent Director$96,960
Jon DuaneIndependent Director$100,960
Julie McHughChair of the Board$136,960
Mark CurrieIndependent Director$95,960
Marla KesslerIndependent Director$95,960
Thomas McCourtDirector$0

The full IRONWOOD PHARMACEUTICALS compensation record

free company brief

This page is one director within IRONWOOD PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy